Clinical Trials Browser

Barrett Esophagus × Dexlansoprazole × Gastrointestinal × Clear all

NCT02162758 2017-05-11

Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation

Phase 2 Terminated

6 enrolled 19 charts

Gastrointestinal

Barrett Esophagus

NCT01093755 2016-03-17

Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?

Phase 4 Completed

30 enrolled 12 charts

Gastrointestinal

Barrett Esophagus, Inflammation